CIK 0001763950 · Non-accelerated filer<br>Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 463973463
- Phone
- 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
Page 1 of 14 · 262 filings